Global Meningococcal Conjugate Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 100

Published Date: 07 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

According to our (Global Info Research) latest study, the global Meningococcal Conjugate market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Meningococcal Conjugate market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Meningococcal Conjugate market size and forecasts, in consumption value ($ Million), 2018-2029
Global Meningococcal Conjugate market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Meningococcal Conjugate market size and forecasts, by Type and by End User, in consumption value ($ Million), 2018-2029
Global Meningococcal Conjugate market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Meningococcal Conjugate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Meningococcal Conjugate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering and JN International Medical Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Meningococcal Conjugate market is split by Type and by End User. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Menactra
    Menveo
    NeisVac-C
    Nimenrix
    Others

Market segment by End User
    Children
    Preteens or Teens
    Adults

Market segment by players, this report covers
    Sanofi Pasteur
    Pfizer
    Glaxo Smith Kline
    Hualan Biological Engineering
    JN International Medical Corporation
    Baxter International
    Merck
    Serum Institute of India
    Biomed
    Novartis

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Meningococcal Conjugate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Meningococcal Conjugate, with revenue, gross margin and global market share of Meningococcal Conjugate from 2018 to 2023.
Chapter 3, the Meningococcal Conjugate competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Meningococcal Conjugate market forecast, by regions, type and end user, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Meningococcal Conjugate.
Chapter 13, to describe Meningococcal Conjugate research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Meningococcal Conjugate
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Meningococcal Conjugate by Type
        1.3.1 Overview: Global Meningococcal Conjugate Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Meningococcal Conjugate Consumption Value Market Share by Type in 2022
        1.3.3 Menactra
        1.3.4 Menveo
        1.3.5 NeisVac-C
        1.3.6 Nimenrix
        1.3.7 Others
    1.4 Global Meningococcal Conjugate Market by End User
        1.4.1 Overview: Global Meningococcal Conjugate Market Size by End User: 2018 Versus 2022 Versus 2029
        1.4.2 Children
        1.4.3 Preteens or Teens
        1.4.4 Adults
    1.5 Global Meningococcal Conjugate Market Size & Forecast
    1.6 Global Meningococcal Conjugate Market Size and Forecast by Region
        1.6.1 Global Meningococcal Conjugate Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Meningococcal Conjugate Market Size by Region, (2018-2029)
        1.6.3 North America Meningococcal Conjugate Market Size and Prospect (2018-2029)
        1.6.4 Europe Meningococcal Conjugate Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Meningococcal Conjugate Market Size and Prospect (2018-2029)
        1.6.6 South America Meningococcal Conjugate Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Meningococcal Conjugate Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Sanofi Pasteur
        2.1.1 Sanofi Pasteur Details
        2.1.2 Sanofi Pasteur Major Business
        2.1.3 Sanofi Pasteur Meningococcal Conjugate Product and Solutions
        2.1.4 Sanofi Pasteur Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Sanofi Pasteur Recent Developments and Future Plans
    2.2 Pfizer
        2.2.1 Pfizer Details
        2.2.2 Pfizer Major Business
        2.2.3 Pfizer Meningococcal Conjugate Product and Solutions
        2.2.4 Pfizer Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Pfizer Recent Developments and Future Plans
    2.3 Glaxo Smith Kline
        2.3.1 Glaxo Smith Kline Details
        2.3.2 Glaxo Smith Kline Major Business
        2.3.3 Glaxo Smith Kline Meningococcal Conjugate Product and Solutions
        2.3.4 Glaxo Smith Kline Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Glaxo Smith Kline Recent Developments and Future Plans
    2.4 Hualan Biological Engineering
        2.4.1 Hualan Biological Engineering Details
        2.4.2 Hualan Biological Engineering Major Business
        2.4.3 Hualan Biological Engineering Meningococcal Conjugate Product and Solutions
        2.4.4 Hualan Biological Engineering Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Hualan Biological Engineering Recent Developments and Future Plans
    2.5 JN International Medical Corporation
        2.5.1 JN International Medical Corporation Details
        2.5.2 JN International Medical Corporation Major Business
        2.5.3 JN International Medical Corporation Meningococcal Conjugate Product and Solutions
        2.5.4 JN International Medical Corporation Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 JN International Medical Corporation Recent Developments and Future Plans
    2.6 Baxter International
        2.6.1 Baxter International Details
        2.6.2 Baxter International Major Business
        2.6.3 Baxter International Meningococcal Conjugate Product and Solutions
        2.6.4 Baxter International Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Baxter International Recent Developments and Future Plans
    2.7 Merck
        2.7.1 Merck Details
        2.7.2 Merck Major Business
        2.7.3 Merck Meningococcal Conjugate Product and Solutions
        2.7.4 Merck Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Merck Recent Developments and Future Plans
    2.8 Serum Institute of India
        2.8.1 Serum Institute of India Details
        2.8.2 Serum Institute of India Major Business
        2.8.3 Serum Institute of India Meningococcal Conjugate Product and Solutions
        2.8.4 Serum Institute of India Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Serum Institute of India Recent Developments and Future Plans
    2.9 Biomed
        2.9.1 Biomed Details
        2.9.2 Biomed Major Business
        2.9.3 Biomed Meningococcal Conjugate Product and Solutions
        2.9.4 Biomed Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Biomed Recent Developments and Future Plans
    2.10 Novartis
        2.10.1 Novartis Details
        2.10.2 Novartis Major Business
        2.10.3 Novartis Meningococcal Conjugate Product and Solutions
        2.10.4 Novartis Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Novartis Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Meningococcal Conjugate Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Meningococcal Conjugate by Company Revenue
        3.2.2 Top 3 Meningococcal Conjugate Players Market Share in 2022
        3.2.3 Top 6 Meningococcal Conjugate Players Market Share in 2022
    3.3 Meningococcal Conjugate Market: Overall Company Footprint Analysis
        3.3.1 Meningococcal Conjugate Market: Region Footprint
        3.3.2 Meningococcal Conjugate Market: Company Product Type Footprint
        3.3.3 Meningococcal Conjugate Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Meningococcal Conjugate Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Meningococcal Conjugate Market Forecast by Type (2024-2029)

5 Market Size Segment by End User
    5.1 Global Meningococcal Conjugate Consumption Value Market Share by End User (2018-2023)
    5.2 Global Meningococcal Conjugate Market Forecast by End User (2024-2029)

6 North America
    6.1 North America Meningococcal Conjugate Consumption Value by Type (2018-2029)
    6.2 North America Meningococcal Conjugate Consumption Value by End User (2018-2029)
    6.3 North America Meningococcal Conjugate Market Size by Country
        6.3.1 North America Meningococcal Conjugate Consumption Value by Country (2018-2029)
        6.3.2 United States Meningococcal Conjugate Market Size and Forecast (2018-2029)
        6.3.3 Canada Meningococcal Conjugate Market Size and Forecast (2018-2029)
        6.3.4 Mexico Meningococcal Conjugate Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Meningococcal Conjugate Consumption Value by Type (2018-2029)
    7.2 Europe Meningococcal Conjugate Consumption Value by End User (2018-2029)
    7.3 Europe Meningococcal Conjugate Market Size by Country
        7.3.1 Europe Meningococcal Conjugate Consumption Value by Country (2018-2029)
        7.3.2 Germany Meningococcal Conjugate Market Size and Forecast (2018-2029)
        7.3.3 France Meningococcal Conjugate Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Meningococcal Conjugate Market Size and Forecast (2018-2029)
        7.3.5 Russia Meningococcal Conjugate Market Size and Forecast (2018-2029)
        7.3.6 Italy Meningococcal Conjugate Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Meningococcal Conjugate Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Meningococcal Conjugate Consumption Value by End User (2018-2029)
    8.3 Asia-Pacific Meningococcal Conjugate Market Size by Region
        8.3.1 Asia-Pacific Meningococcal Conjugate Consumption Value by Region (2018-2029)
        8.3.2 China Meningococcal Conjugate Market Size and Forecast (2018-2029)
        8.3.3 Japan Meningococcal Conjugate Market Size and Forecast (2018-2029)
        8.3.4 South Korea Meningococcal Conjugate Market Size and Forecast (2018-2029)
        8.3.5 India Meningococcal Conjugate Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Meningococcal Conjugate Market Size and Forecast (2018-2029)
        8.3.7 Australia Meningococcal Conjugate Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Meningococcal Conjugate Consumption Value by Type (2018-2029)
    9.2 South America Meningococcal Conjugate Consumption Value by End User (2018-2029)
    9.3 South America Meningococcal Conjugate Market Size by Country
        9.3.1 South America Meningococcal Conjugate Consumption Value by Country (2018-2029)
        9.3.2 Brazil Meningococcal Conjugate Market Size and Forecast (2018-2029)
        9.3.3 Argentina Meningococcal Conjugate Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Meningococcal Conjugate Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Meningococcal Conjugate Consumption Value by End User (2018-2029)
    10.3 Middle East & Africa Meningococcal Conjugate Market Size by Country
        10.3.1 Middle East & Africa Meningococcal Conjugate Consumption Value by Country (2018-2029)
        10.3.2 Turkey Meningococcal Conjugate Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Meningococcal Conjugate Market Size and Forecast (2018-2029)
        10.3.4 UAE Meningococcal Conjugate Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Meningococcal Conjugate Market Drivers
    11.2 Meningococcal Conjugate Market Restraints
    11.3 Meningococcal Conjugate Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Meningococcal Conjugate Industry Chain
    12.2 Meningococcal Conjugate Upstream Analysis
    12.3 Meningococcal Conjugate Midstream Analysis
    12.4 Meningococcal Conjugate Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Meningococcal Conjugate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Meningococcal Conjugate Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Meningococcal Conjugate Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Meningococcal Conjugate Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Sanofi Pasteur Company Information, Head Office, and Major Competitors
    Table 6. Sanofi Pasteur Major Business
    Table 7. Sanofi Pasteur Meningococcal Conjugate Product and Solutions
    Table 8. Sanofi Pasteur Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Sanofi Pasteur Recent Developments and Future Plans
    Table 10. Pfizer Company Information, Head Office, and Major Competitors
    Table 11. Pfizer Major Business
    Table 12. Pfizer Meningococcal Conjugate Product and Solutions
    Table 13. Pfizer Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Pfizer Recent Developments and Future Plans
    Table 15. Glaxo Smith Kline Company Information, Head Office, and Major Competitors
    Table 16. Glaxo Smith Kline Major Business
    Table 17. Glaxo Smith Kline Meningococcal Conjugate Product and Solutions
    Table 18. Glaxo Smith Kline Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Glaxo Smith Kline Recent Developments and Future Plans
    Table 20. Hualan Biological Engineering Company Information, Head Office, and Major Competitors
    Table 21. Hualan Biological Engineering Major Business
    Table 22. Hualan Biological Engineering Meningococcal Conjugate Product and Solutions
    Table 23. Hualan Biological Engineering Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Hualan Biological Engineering Recent Developments and Future Plans
    Table 25. JN International Medical Corporation Company Information, Head Office, and Major Competitors
    Table 26. JN International Medical Corporation Major Business
    Table 27. JN International Medical Corporation Meningococcal Conjugate Product and Solutions
    Table 28. JN International Medical Corporation Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. JN International Medical Corporation Recent Developments and Future Plans
    Table 30. Baxter International Company Information, Head Office, and Major Competitors
    Table 31. Baxter International Major Business
    Table 32. Baxter International Meningococcal Conjugate Product and Solutions
    Table 33. Baxter International Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Baxter International Recent Developments and Future Plans
    Table 35. Merck Company Information, Head Office, and Major Competitors
    Table 36. Merck Major Business
    Table 37. Merck Meningococcal Conjugate Product and Solutions
    Table 38. Merck Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Merck Recent Developments and Future Plans
    Table 40. Serum Institute of India Company Information, Head Office, and Major Competitors
    Table 41. Serum Institute of India Major Business
    Table 42. Serum Institute of India Meningococcal Conjugate Product and Solutions
    Table 43. Serum Institute of India Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Serum Institute of India Recent Developments and Future Plans
    Table 45. Biomed Company Information, Head Office, and Major Competitors
    Table 46. Biomed Major Business
    Table 47. Biomed Meningococcal Conjugate Product and Solutions
    Table 48. Biomed Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Biomed Recent Developments and Future Plans
    Table 50. Novartis Company Information, Head Office, and Major Competitors
    Table 51. Novartis Major Business
    Table 52. Novartis Meningococcal Conjugate Product and Solutions
    Table 53. Novartis Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Novartis Recent Developments and Future Plans
    Table 55. Global Meningococcal Conjugate Revenue (USD Million) by Players (2018-2023)
    Table 56. Global Meningococcal Conjugate Revenue Share by Players (2018-2023)
    Table 57. Breakdown of Meningococcal Conjugate by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Meningococcal Conjugate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 59. Head Office of Key Meningococcal Conjugate Players
    Table 60. Meningococcal Conjugate Market: Company Product Type Footprint
    Table 61. Meningococcal Conjugate Market: Company Product Application Footprint
    Table 62. Meningococcal Conjugate New Market Entrants and Barriers to Market Entry
    Table 63. Meningococcal Conjugate Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Meningococcal Conjugate Consumption Value (USD Million) by Type (2018-2023)
    Table 65. Global Meningococcal Conjugate Consumption Value Share by Type (2018-2023)
    Table 66. Global Meningococcal Conjugate Consumption Value Forecast by Type (2024-2029)
    Table 67. Global Meningococcal Conjugate Consumption Value by End User (2018-2023)
    Table 68. Global Meningococcal Conjugate Consumption Value Forecast by End User (2024-2029)
    Table 69. North America Meningococcal Conjugate Consumption Value by Type (2018-2023) & (USD Million)
    Table 70. North America Meningococcal Conjugate Consumption Value by Type (2024-2029) & (USD Million)
    Table 71. North America Meningococcal Conjugate Consumption Value by End User (2018-2023) & (USD Million)
    Table 72. North America Meningococcal Conjugate Consumption Value by End User (2024-2029) & (USD Million)
    Table 73. North America Meningococcal Conjugate Consumption Value by Country (2018-2023) & (USD Million)
    Table 74. North America Meningococcal Conjugate Consumption Value by Country (2024-2029) & (USD Million)
    Table 75. Europe Meningococcal Conjugate Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Europe Meningococcal Conjugate Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Europe Meningococcal Conjugate Consumption Value by End User (2018-2023) & (USD Million)
    Table 78. Europe Meningococcal Conjugate Consumption Value by End User (2024-2029) & (USD Million)
    Table 79. Europe Meningococcal Conjugate Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe Meningococcal Conjugate Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific Meningococcal Conjugate Consumption Value by Type (2018-2023) & (USD Million)
    Table 82. Asia-Pacific Meningococcal Conjugate Consumption Value by Type (2024-2029) & (USD Million)
    Table 83. Asia-Pacific Meningococcal Conjugate Consumption Value by End User (2018-2023) & (USD Million)
    Table 84. Asia-Pacific Meningococcal Conjugate Consumption Value by End User (2024-2029) & (USD Million)
    Table 85. Asia-Pacific Meningococcal Conjugate Consumption Value by Region (2018-2023) & (USD Million)
    Table 86. Asia-Pacific Meningococcal Conjugate Consumption Value by Region (2024-2029) & (USD Million)
    Table 87. South America Meningococcal Conjugate Consumption Value by Type (2018-2023) & (USD Million)
    Table 88. South America Meningococcal Conjugate Consumption Value by Type (2024-2029) & (USD Million)
    Table 89. South America Meningococcal Conjugate Consumption Value by End User (2018-2023) & (USD Million)
    Table 90. South America Meningococcal Conjugate Consumption Value by End User (2024-2029) & (USD Million)
    Table 91. South America Meningococcal Conjugate Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. South America Meningococcal Conjugate Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Middle East & Africa Meningococcal Conjugate Consumption Value by Type (2018-2023) & (USD Million)
    Table 94. Middle East & Africa Meningococcal Conjugate Consumption Value by Type (2024-2029) & (USD Million)
    Table 95. Middle East & Africa Meningococcal Conjugate Consumption Value by End User (2018-2023) & (USD Million)
    Table 96. Middle East & Africa Meningococcal Conjugate Consumption Value by End User (2024-2029) & (USD Million)
    Table 97. Middle East & Africa Meningococcal Conjugate Consumption Value by Country (2018-2023) & (USD Million)
    Table 98. Middle East & Africa Meningococcal Conjugate Consumption Value by Country (2024-2029) & (USD Million)
    Table 99. Meningococcal Conjugate Raw Material
    Table 100. Key Suppliers of Meningococcal Conjugate Raw Materials
List of Figures
    Figure 1. Meningococcal Conjugate Picture
    Figure 2. Global Meningococcal Conjugate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Meningococcal Conjugate Consumption Value Market Share by Type in 2022
    Figure 4. Menactra
    Figure 5. Menveo
    Figure 6. NeisVac-C
    Figure 7. Nimenrix
    Figure 8. Others
    Figure 9. Global Meningococcal Conjugate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Meningococcal Conjugate Consumption Value Market Share by End User in 2022
    Figure 11. Children Picture
    Figure 12. Preteens or Teens Picture
    Figure 13. Adults Picture
    Figure 14. Global Meningococcal Conjugate Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Meningococcal Conjugate Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Meningococcal Conjugate Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Meningococcal Conjugate Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Meningococcal Conjugate Consumption Value Market Share by Region in 2022
    Figure 19. North America Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Meningococcal Conjugate Revenue Share by Players in 2022
    Figure 25. Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Meningococcal Conjugate Market Share in 2022
    Figure 27. Global Top 6 Players Meningococcal Conjugate Market Share in 2022
    Figure 28. Global Meningococcal Conjugate Consumption Value Share by Type (2018-2023)
    Figure 29. Global Meningococcal Conjugate Market Share Forecast by Type (2024-2029)
    Figure 30. Global Meningococcal Conjugate Consumption Value Share by End User (2018-2023)
    Figure 31. Global Meningococcal Conjugate Market Share Forecast by End User (2024-2029)
    Figure 32. North America Meningococcal Conjugate Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Meningococcal Conjugate Consumption Value Market Share by End User (2018-2029)
    Figure 34. North America Meningococcal Conjugate Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Meningococcal Conjugate Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Meningococcal Conjugate Consumption Value Market Share by End User (2018-2029)
    Figure 40. Europe Meningococcal Conjugate Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Meningococcal Conjugate Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Meningococcal Conjugate Consumption Value Market Share by End User (2018-2029)
    Figure 48. Asia-Pacific Meningococcal Conjugate Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Meningococcal Conjugate Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Meningococcal Conjugate Consumption Value Market Share by End User (2018-2029)
    Figure 57. South America Meningococcal Conjugate Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Meningococcal Conjugate Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Meningococcal Conjugate Consumption Value Market Share by End User (2018-2029)
    Figure 62. Middle East and Africa Meningococcal Conjugate Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 66. Meningococcal Conjugate Market Drivers
    Figure 67. Meningococcal Conjugate Market Restraints
    Figure 68. Meningococcal Conjugate Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Meningococcal Conjugate in 2022
    Figure 71. Manufacturing Process Analysis of Meningococcal Conjugate
    Figure 72. Meningococcal Conjugate Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi Pasteur
Pfizer
Glaxo Smith Kline
Hualan Biological Engineering
JN International Medical Corporation
Baxter International
Merck
Serum Institute of India
Biomed
Novartis

Related Reports

Global Meningococcal Conjugate Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Meningococcal Conjugate Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 03 Jul 2021

date Medical Care

The Meningococcal Conjugate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Meningococcal Conjugate Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Meningococcal Conjugate Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 08 Jan 2022

date Medical Care

Global Meningococcal Conjugate Supply, Demand and Key Producers, 2023-2029

Global Meningococcal Conjugate Supply, Demand and Key Producers, 2023-2029

date 12 Feb 2023

date Medical Care

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

Global Meningococcal Conjugate Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Meningococcal Conjugate Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Meningococcal Conjugate market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

meningococcal conjugate

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>